Table 2.
Xenograft frequency with lineage-depleted and fractionated epithelial cells from prostate cancers: tumor incidence after subcutaneous xenografts with serially diluted cell populations
| Cell population | No. tumors/no. grafted | |||
|---|---|---|---|---|
| No. cells/graft (latency) | ||||
| 105 | 104 | 103 | 102 | |
| Unsorted | 4/4 (40) | 2/2 (35) | 0/2 | 0/2 |
| CD44+ | 2/2 (45) | – | – | – |
| CD133+ | – | 1/2 (50) | 1/4 (92) | 1/4 (163) |
| CD24+ | 1/2 (55) | 1/2 (43) | 1/2 (68) | – |